Clinical Trial Update: SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SPECT-CT guided elective contralateral neck treatment for lateralized oropharyngeal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Oropharyngeal Cancer | Phase 3 | Status: RECRUITING